*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Study of LD50 and chronic toxicity of suspension of Silver nanoparticles size 50 nm in laboratory rats

Author: NINO CHICHIVEISHVILI, TEIMURAZ TAVKHELIDZE, SALOME KHUBULAVA, GIORGI PITCHKHAIA, JENARA KRISTESASHVILI, DAVIT KACADZE
Abstract: Antibiotic era is coming to the end, becouse of the wrong selecting of antibiotics and combination therapy and the mutation skills of bacteria. In recent years, the use of nanosilver particles for therapeutic purposes has become more relevant. These particles have an antibacterial effect and a fairly good effect on local inflammatory processes. We made suspension of silver nanoparticles size 50 nm by the physic method and introduced into laboratory rats. Our studies demonstrates that argentium nano-particles can be administered in physical (non-chemical) pathways. It does not have LD50, however, its consumption with high doses for prolonged period of time leads to histomorphological changes in healthy tissues.
Keyword: silver nanoparticles, Drug toxicity.a
DOI: https://doi.org/10.31838/ijpr/2019.11.01.121
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free